Disney Enterprises, Inc., along with several related entertainment companies, filed a lawsuit against Midjourney, Inc., last week, accusing the AI company of copyright infringement. The complaint, ...

Short seller Christian Lamarco likes to court controversy. When he founded his New York firm in 2019, he named it Culper Research – after the Culper Spy Ring, which operated during the American ...

As celebrity brands boom, Hailey Bieber’s rhode announced it will be acquired by e.l.f. Beauty for as much as $1 billion. The consideration consists of $800 million at closing in a mix of cash ...

Last Friday, the Securities and Exchange Commission (SEC) announced that KT Corporation agreed to resolve allegations that it violated the Foreign Corrupt Practices Act (FCPA) in a cease and ...

On Tuesday, Decapolis Systems, LLC filed a complaint in the Eastern District of Texas against Texas Retina Associates and Surgery Partners, Inc. alleging patent infringement. According to the ...

Chase Herro, a self-proclaimed “dirtbag of the internet,” is a fast-talking serial entrepreneur and dealmaker with a colorful backstory and a lot of legal baggage, as recounted last year in a ...

As celebrity brands boom, Hailey Bieber’s rhode announced it will be acquired by e.l.f. Beauty for as much as $1 billion. The consideration consists of $800 million at closing in a mix of cash and ...

On Monday, a group of dairy farmers filed a class action lawsuit in the District of New Mexico against Dairy Farmers of America, Inc. (DFA), Select Milk Producers, Inc. (Select Milk) and Greater ...

An amended complaint filed in Massachusetts federal court on Monday has accused the United States Department of Defense, the United States Navy, and contractors Raytheon Technologies Corporation ...

Bank consolidation has intensified, with a pair of bank mergers announced just a day apart: Columbia Banking System, Inc. announced plans to acquire Pacific Premier Bancorp, Inc. for $2 billion and ...

Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a ...